This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
patent system by the pharmaceutical industry, moves by some drugmakers to expand their patent claims appear to be delaying the arrival of lower-cost genericmedicines to the marketplace, according to a STAT analysis. Amid debate over potential abuse of the U.S.
Patent and Trademark Office has proposed a new rule designed to stem the use of so-called patent thickets , which are wielded by pharmaceutical companies to delay the arrival of lower-cost genericmedicines in the marketplace.
Specifically, the proposed rule was crafted to stem the use of so-called patent thickets , which are wielded by drug companies to delay the arrival of lower-cost genericmedicines in the marketplace.
The chemo drug in question, Imatinib, costs $17,000 at CVS and just $72 at Cost Plus Drugs. But it’s a genericmedicine — which means PBMs’ negotiating techniques don’t apply. Genericdrugs compete on price. Continue to STAT+ to read the full story…
In a bid to resolve both physical and financial restrictions inhibiting equitable access to quality medicines, the Jan Aushadhi scheme was launched in 2008 and envisaged the setting up of dedicated Janaushadhi Kendras to provide quality genericmedicines at capped prices for the general public.
The deductions work as follows: Branded Medicines (Part VIIIA Category C) : 5% discount GenericMedicines (Part VIIIA Categories A and M) : 20% discount Appliances (Part IX) : 9.85% discount Understanding these deductions is critical, especially when many medicines are unavailable at or below the Drug Tariff price.
It is a new type of medicine that works by stimulating a pair of muscarinic receptors in the brain, that, in turn, control the release of a brain chemical called acetylcholine. Current antipsychotics, which include genericmedicines and branded products, mostly regulate mood by blocking dopamine receptors.
Inflation can damage production viability of European drugs. Once a drug’s patent expires, numerous pharma companies offer generic versions, which can then reduce drugpricing by as much as 80-90%, leading to small profit margins for generics makers.
WASHINGTON — Generic drugmakers lobbied hard against Democrats’ new law empowering Medicare to negotiate prescription drugprices. Giving the government such power seemed like an admission that genericmedicines don’t do enough to keep costs down.
The US imports a substantial volume of APIs and finished medicines, many of which are essential for patient care, meaning these tariffs could have far-reaching implications. 1 Here, we explore the potential impact of tariffs on pharmaceutical supply chains, pricing, investment and industry strategy.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content